A detailed history of Bradley Foster & Sargent Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bradley Foster & Sargent Inc holds 1,796 shares of VRTX stock, worth $902,400. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,796
Previous 1,896 5.27%
Holding current value
$902,400
Previous $888,000 5.97%
% of portfolio
0.01%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$460.0 - $505.78 $46,000 - $50,578
-100 Reduced 5.27%
1,796 $835,000
Q2 2024

Aug 09, 2024

BUY
$392.81 - $485.53 $15,712 - $19,421
40 Added 2.16%
1,896 $888,000
Q1 2024

May 15, 2024

SELL
$407.69 - $446.08 $360,397 - $394,334
-884 Reduced 32.26%
1,856 $775,000
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $18,865 - $22,587
55 Added 2.05%
2,740 $1.11 Million
Q2 2023

Aug 08, 2023

BUY
$314.42 - $351.91 $4,087 - $4,574
13 Added 0.49%
2,685 $944,000
Q4 2022

Feb 14, 2023

SELL
$285.76 - $321.48 $2,857 - $3,214
-10 Reduced 0.37%
2,672 $771,000
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $33,954 - $37,885
124 Added 4.85%
2,682 $777,000
Q2 2022

Aug 11, 2022

BUY
$234.96 - $292.55 $181,389 - $225,848
772 Added 43.23%
2,558 $721,000
Q1 2022

May 16, 2022

BUY
$221.42 - $260.97 $13,728 - $16,180
62 Added 3.6%
1,786 $466,000
Q4 2021

Mar 11, 2022

SELL
$177.01 - $223.45 $72,574 - $91,614
-410 Reduced 19.21%
1,724 $379,000
Q3 2021

Nov 10, 2021

SELL
$181.39 - $202.99 $17.9 Million - $20 Million
-98,754 Reduced 97.88%
2,134 $387,000
Q2 2021

Aug 19, 2021

BUY
$187.49 - $221.1 $143,054 - $168,699
763 Added 0.76%
100,888 $20.3 Million
Q1 2021

Apr 26, 2021

BUY
$207.02 - $241.31 $19.9 Million - $23.2 Million
96,333 Added 2540.43%
100,125 $21.5 Million
Q4 2020

Feb 11, 2021

BUY
$207.01 - $276.09 $77,007 - $102,705
372 Added 10.88%
3,792 $896,000
Q4 2019

Jan 29, 2020

BUY
$166.71 - $223.91 $104,860 - $140,839
629 Added 22.54%
3,420 $749,000
Q3 2019

Oct 30, 2019

BUY
$166.23 - $187.09 $149,440 - $168,193
899 Added 47.52%
2,791 $473,000
Q2 2019

Aug 08, 2019

SELL
$164.61 - $190.37 $102,881 - $118,981
-625 Reduced 24.83%
1,892 $347,000
Q1 2019

May 02, 2019

BUY
$163.73 - $194.7 $2,783 - $3,309
17 Added 0.68%
2,517 $463,000
Q4 2018

Jan 30, 2019

BUY
$151.91 - $192.21 $127,148 - $160,879
837 Added 50.33%
2,500 $414,000
Q2 2018

Jul 31, 2018

BUY
$145.72 - $169.96 $31,038 - $36,201
213 Added 14.69%
1,663 $283,000
Q1 2018

May 07, 2018

BUY
$151.6 - $177.13 $219,820 - $256,838
1,450 New
1,450 $236,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Bradley Foster & Sargent Inc Portfolio

Follow Bradley Foster & Sargent Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bradley Foster & Sargent Inc with notifications on news.